<?xml version="1.0" encoding="UTF-8"?>
<p id="par0170">We hope that the data and their analyses presented in this article will stimulate both the funding agencies (governmental, private, etc.) and the scientific community to maintain their interest in searching for an efficient treatment for COVID-19, given the comparison with previous, large-scale epidemics. Given the unprecedented increase in clinical trials and publications, the growing public interest in the disease, and the looming threat of a future outbreak, it is unlikely that these trends will die down in the coming months and years. Vaccine development for COVID-19 is occurring at an unprecedented pace: on average, vaccine development takes 10 years, but there is a hope to have a vaccine available for emergency use by early 2021 
 <xref rid="bib0240" ref-type="bibr">[48]</xref>. However, global research efforts need to become more focused if we are to combat this pandemic effectively.
</p>
